Morning Headlines 12/27/24
A CNBC analysis of 39 publicly traded digital health companies finds that two-thirds lost value in 2024 ,with high-profile stumbles by Teladoc Health, Progyny, GoodRx, Dexcom, and 23andMe.
Researchers find that CMS’s four-year-old program that encourages a home alternative to hospital admission will need to offer different incentives to expand to smaller, rural, and non-teaching hospitals.
Providers Used Medicare Part D Eligibility Verification Transactions for Permissible Purposes
An HHS OIG investigation finds minimal improper use of Medicare Part D prescription eligibility transactions by providers after CMS tightened controls.
Telemedicine provider Avel ECare acquires Hospital Pharmacy Management, which offers remote pharmacy order verification and hospital pharmacy management.
Forgive my skepticism but I doubt having a couple of vendors on DOGE will do anything to improve healthcare cost,…